[HTML][HTML] The role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome
K Bednarz, K Kowalczyk, M Cwynar, D Czapla… - International journal of …, 2022 - mdpi.com
Insulin resistance is documented in clamp studies in 75% of women with polycystic ovary
syndrome (PCOS). Although it is not included in the diagnostic criteria of PCOS, there is a …
syndrome (PCOS). Although it is not included in the diagnostic criteria of PCOS, there is a …
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis
BACKGROUND Polycystic ovary syndrome (PCOS) is a common endocrine disorder with
diverse reproductive and metabolic features. It is underpinned by insulin resistance that is …
diverse reproductive and metabolic features. It is underpinned by insulin resistance that is …
American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with …
WT Garvey, JI Mechanick, EM Brett, AJ Garber… - Endocrine Practice, 2016 - Elsevier
Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …
Clinical Endocrinologists (AACE) Board of Directors and the American College of …
[HTML][HTML] Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized …
KE Elkind-Hirsch, N Chappell, D Shaler, J Storment… - Fertility and sterility, 2022 - Elsevier
Objective To study the efficacy and safety of the GLP-1 analog liraglutide 3 mg (LIRA 3 mg)
vs. placebo (PL) for reduction of body weight (BW) and hyperandrogenism in women with …
vs. placebo (PL) for reduction of body weight (BW) and hyperandrogenism in women with …
The current and potential therapeutic use of metformin—the good old drug
J Drzewoski, M Hanefeld - Pharmaceuticals, 2021 - mdpi.com
Metformin, one of the oldest oral antidiabetic agents and still recommended by almost all
current guidelines as the first-line treatment for type 2 diabetes mellitus (T2DM), has become …
current guidelines as the first-line treatment for type 2 diabetes mellitus (T2DM), has become …
Insulin‐sensitising drugs (metformin, rosiglitazone, pioglitazone, D‐chiro‐inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
Background Polycystic ovary syndrome (PCOS) is characterised by infrequent or absent
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …
ovulation, and high levels of androgens and insulin (hyperinsulinaemia). Hyperinsulinaemia …
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: a randomized clinical trial
S Frøssing, M Nylander, E Chabanova… - Diabetes, Obesity …, 2018 - Wiley Online Library
Women with polycystic ovary syndrome (PCOS) were treated with the GLP‐1 receptor
agonist liraglutide to investigate the effect on liver fat content, visceral adipose tissue (VAT) …
agonist liraglutide to investigate the effect on liver fat content, visceral adipose tissue (VAT) …
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome
M Siamashvili, SN Davis - Expert review of clinical pharmacology, 2021 - Taylor & Francis
ABSTRACT Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) offer a
unique opportunity to simultaneously address various comorbid associated conditions and …
unique opportunity to simultaneously address various comorbid associated conditions and …
Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis
CH Kim, SJ Chon, SH Lee - Scientific reports, 2020 - nature.com
Polycystic ovary syndrome (PCOS) is a common disease that has an effect on approximately
10% of women of childbearing age. Although there is evidence regarding the role of lifestyle …
10% of women of childbearing age. Although there is evidence regarding the role of lifestyle …
The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective
M Jensterle, A Janez, E Fliers… - Human reproduction …, 2019 - academic.oup.com
Abstract BACKGROUND Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs)
have become firmly established in the treatment of type 2 diabetes and obesity, disorders …
have become firmly established in the treatment of type 2 diabetes and obesity, disorders …